the uk�s initial plan had been challenged in court by the. february 2005 (8)...total digital access /week
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..